David Blumberg
Founder & Managing Partner @ Blumberg Capital
Miami, United States
David Blumberg is a Series A investor at Blumberg Capital in Miami focused on Software and FinTech. David is the founder and managing partner of Blumberg Capital. David is an authority on early-stage investing with decades of experience. He founded Blumberg Capital in the early 1990s and launched its first venture-backed fund in 2001.Prior to Blumberg Capital, David managed international investments with the Bronfman Family Office, Adler &Co, APAX Partners and at T. Rowe Price. He also launched business development for Check Point Software Technologies as one of its top four executives.David earned his A.B. in Government, cum laude, from Harvard College and his MBA from the Stanford Graduate School of Business and INSEAD. David speaks French and is proficient in Hebrew and Spanish.
- Total investments:
- 66
- Last investment:
- Lead investor:
- 27%
Last updated:
For AI agents: llms.txt
Industries David Blumberg invests in
Stages David Blumberg invests in
Countries David Blumberg invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 10 (15%)
- FinTech 7 (11%)
- Analytics 6 (9%)
- Advertising 6 (9%)
- Financial Services 6 (9%)
Stage
- Series A 19 (29%)
- Series B 13 (20%)
- Seed 8 (12%)
- Series C 6 (9%)
- Series D 4 (6%)
Country
- United States 23 (35%)
- Israel 3 (5%)
- Germany 3 (5%)
- Canada 2 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Angle Health provides a technology-enabled health insurance platform to simplify employer-sponsored healthcare benefits. | $200M / Series C / Sep 18, 2026 | ||
| Angle Health provides a technology-enabled health insurance platform to simplify employer-sponsored healthcare benefits. The company's service offers fully configurable group health plans that employers can tailor and deploy quickly through its “Benefit Builder” and “Quote-to-Card” tools, often eliminating the need for individual member-levelunderwriting. It integrates medical, pharmacy, demographic, claims, and population-health data with AI-enabled analytics to help employers, brokers, and care teams anticipate health needs and design plans accordingly.Angle Health’s plans typically include telemedicine, digital behavioral health, chronic-disease management, and access to a national network of doctors and providers—services that are often bundled into standard coverage. | $134M / Series B / Dec 03, 2025 | ||
| Segmed offers extensive clinical data and diagnostic-grade medical images to support life sciences and technology industries. The company facilitates rapid discovery and development of predictive models, improving patient recruitment and data management. Its solutions cater to pharmaceutical and medical device sectors, enhancing research andregulatory processes. | $10.4M / Series A / Sep 03, 2024 | ||
| Tellen builds enterprise AI infrastructure enabling accounting firms to launch secure and compliant generative AI solutions for employees and clients. It enables firms to build, deploy, and operate AI applications to improve productivity and enhance quality. In an industry facing a massive shortage of skilled talent and a huge demand for accountingwork, Tellen's Accounting AI Studio will help firms quickly, painlessly, and responsibly adopt generative AI technology as part of their digital transformation. | $2M / Pre-Seed / Aug 01, 2024 | ||
| Pontera, formerly FeeX, bridges the gap between a better retirement and financial advisors by allowing them to manage and trade their clients' held away accounts. Its goal is to help people retire with more wealth and financial security. The company, which was founded in 2012, works with RIAs, Broker-Dealers, and some of the country'slargest financial institutions. | $60M / Venture - Series Unknown / Dec 07, 2023 | ||
| Kloudfuse is an observability datalake that scales cost-effectively. Kloudfuse AI takes observability data to the next level. For the quickest possible troubleshooting, Kloudfuse's HawkEye and BullsEye analytics engine produces intelligent auto-alerts, contextualizes across streams, and effectively filters noise. The company makes it possibleto get the best ROI from observability data by offering unlimited data at a vastly reduced cost. | $17M / Series A / Nov 06, 2023 | ||
| Angle Health provides a technology-enabled health insurance platform to simplify employer-sponsored healthcare benefits. The company's service offers fully configurable group health plans that employers can tailor and deploy quickly through its “Benefit Builder” and “Quote-to-Card” tools, often eliminating the need for individual member-levelunderwriting. It integrates medical, pharmacy, demographic, claims, and population-health data with AI-enabled analytics to help employers, brokers, and care teams anticipate health needs and design plans accordingly.Angle Health’s plans typically include telemedicine, digital behavioral health, chronic-disease management, and access to a national network of doctors and providers—services that are often bundled into standard coverage. | $58M / Series A / Jan 25, 2023 | ||
| Wunder Mobility is a software and hardware provider for vehicle sharing. Its highly customizable and deeply integrated software solution is complemented by a sharing-ready vehicle program built in partnership with manufacturers. | $11.9M / Series B / Oct 05, 2022 | ||
| Founded in 2020, Miami-based Mytaverse, Inc. was formed to meet the rising demand for 3D, digitally visualized, hybrid workspaces. As a fully immersive ecosystem using Epic Games Unreal Engine, GathR utilizes dynamic experiences for job simulations, interactive meetings, and 3D asset-rich showrooms. Mytaverse's hardware-agnostic approachallows users to enter from anywhere using only their browser on a PC or Mac. The GathR mobile app will be available soon, allowing users to interact with us from any location and at any time. the hardware-agnostic approach allows users from anywhere to enter using only their browser on a PC or Mac. The Mytaverse mobile version will be available soon, allowing users to interact with us from anywhere, at any time. | $7.6M / Series A / Apr 18, 2022 | ||
| EarnUp is a consumer-first fintech platform that intelligently automates loan payments for the more than 200 million Americans with debt. They help you put a few dollars aside for your loans when you can afford it – then they make your loan payments for you, allocating funds in the way that gets you out of debt faster. They are dedicated to givingcontrol back to everyone who is frustrated managing their finances | $31M / Series C / Mar 15, 2022 | ||
| See all 66 investments → | |||
Co-Investors
About Blumberg Capital
Blumberg Capital is an early-stage venture capital firm that partners with visionary entrepreneurs to build successful technology companies that empower individuals, businesses and society through the innovative use of AI, big data and other transformative technologies. We are passionate about nurturing B2B technology companies from Seed stagethrough their growth journey, as active board members and hands-on advisors. We were among the first investors in industry leaders including Addepar, Braze, Credorax, DoubleVerify, Fundbox, HootSuite, Katapult, Nutanix, Trulioo and Yotpo. Find us in San Francisco, Tel Aviv, Miami and New York or at blumbergcapital.com.
Blumberg Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Lisa McNamara
VP of Finance
|
|||
Steve Gillan
COO and CFO
|
|||
Bruce Taragin
Managing Director
|
|||
|
David Blumberg
Founder & Managing Partner
|
|||
Ilia Shnaidman
Vice President
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does David Blumberg invest in?
David Blumberg invests primarily in Software, FinTech and Analytics startups, most often at Series A and Series B stage. Most of the 66 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact David Blumberg?
Public channels for David Blumberg include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did David Blumberg last invest?
The most recent investment recorded for David Blumberg closed in Sep 2026. Shizune tracks 66 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
